Pharma Stocks Face Investor Backlash
Investors have been expressing their discontent with the financial results and corporate strategies of drugmakers in recent days. Bristol Myers Squibb (BMY) witnessed a 3.6% drop in shares following the…
Investors have been expressing their discontent with the financial results and corporate strategies of drugmakers in recent days. Bristol Myers Squibb (BMY) witnessed a 3.6% drop in shares following the…
Stock futures indicate a flat start for Wall Street on Wednesday, following the S&P 500's third-consecutive winning session and its best performance since June. Tesla's AI Computing Cluster Sparks Interest…